Zepbound Patients in Panic Mode as Pharmacies Can’t Get Enough
Eli Lilly’s new weight-loss shot is on backorder across the US, even as the FDA says there’s adequate supply.
People across the US are struggling to get their hands on the powerful new obesity drug Zepbound, even as the FDA and Eli Lilly deny there's a shortage.
Photographer: Shelby Knowles/BloombergPatients, doctors and pharmacists across the US are struggling to get their hands on Eli Lilly & Co.’s powerful new obesity drug Zepbound, as demand for the weight-loss shot soars.
In San Diego, California Shannon Lucero called 8 pharmacies trying to fill her Zepbound prescription. When she called Express Scripts, her pharmacy benefit manager, she was told the dose she needed would be out of stock until at least April 7, sending her into “panic mode.” In Monroe, Michigan, Rachael Altenburg said she spent three days calling more than 10 pharmacies to find one that could fill her prescription.